Clinical and Pharmacological Determinants of the Therapeutic Response to Dihydroartemisinin-Piperaquine for Drug-Resistant Malaria

Dihydroartemisinin-piperaquine (DHP) is an important new treatment for drug-resistant malaria, although pharmacokinetic studies on the combination are limited. In Papua, Indonesia, we assessed determinants of the therapeutic efficacy of DHP for uncomplicated malaria. Plasma piperaquine concentration...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Price, R. N., Hasugian, A. R., Ratcliff, A., Siswantoro, H., Purba, H. L. E., Kenangalem, E., Lindegardh, N., Penttinen, P., Laihad, F., Ebsworth, E. P., Anstey, N. M., Tjitra, E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2007
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2151469/
https://ncbi.nlm.nih.gov/pubmed/17846129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00486-07
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados